SCSiobhan B. Cashman

Siobhan B. Cashman

*This is an algorithmically generated author record based on publicly available information.

Siobhan B. Cashman has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Characterization of germinal center and circulating T follicular helper cells using both intracellular and surface CITE-seq

    by Siobhán B Cashman, Teresa Swift, Hye-Won Song, Adam Wright, Aruna Ayer

    T follicular helper (TFH) cells are a CD4+ T cell subset that play a critical role in the formation of germinal centers (GC). TFH cells are essential to produce protective antibody responses through regulation of clonal selection & differentiation into activated antibody-secreting & memory B cells. TFH cell differentiation is a multistep process that begins with presentation of antigen by dendritic cells to naïve CD4+ T cells, where CD4+ T cells commit to the TFH lineage by expressing the lineage defining transcription factor B cell lymphoma 6 (Bcl-6). TFH cells are phenotypically characterized by high expression of C-X-C chemokine receptor 5 (CXCR5) & programmed cell death-1 (PD-1) on the cell surface. CXCR5+ memory CD4+ T cells present in peripheral blood represent a circulating TFH (cTFH) cell subset. In contrast to TFH cells, cTFH cells may express low levels of Bcl-6 with numerous reports of subsets that differ both phenotypically & functionally. Here we characterise the heterogeneous subsets of TFH & cTFH cells using a combination of intracellular CITE-seq, surface CITE-seq and whole transcriptome single-cell RNA sequencing (scRNA-seq) analysis. Germinal center and circulating TFH cells were enriched by sorting memory CD4+, CXCR5+, PD-1+, and memory CD4+ CXCR5+ cells, respectively. We examined the expression of Bcl-6 & other transcription factors, using protein and RNA expression data, across pre-TFH, TFH & cTFH cells. Together, these data demonstrate how a combination of intracellular CITE-seq, surface CITE-seq & scRNA-seq may be used to deepen our understanding of the differentiation states & subsets of cells present at low abundance, by enabling detection of intracellular and surface protein along with high-quality mRNA.

  • Open Access

    Slp‐76 is a critical determinant of NK‐cell mediated recognition of missing‐self targets

    by Kristin Lampe, Mehari Endale, Siobhan Cashman, Hao Fang, Jochen Mattner, David Hildeman, Kasper Hoebe

    Absence of MHC class I expression is an important mechanism by which NK cells recognize a variety of target cells, yet the pathways underlying “missing‐self” recognition, including the involvement of activating receptors, remain poorly understood. Using ethyl‐N‐nitrosourea mutagenesis in mice, we identified a germline mutant, designated Ace, with a marked defect in NK cell mediated recognition and elimination of “missing‐self” targets. The causative mutation was linked to chromosome 11 and identified as a missense mutation (Thr428Ile) in the SH2 domain of Slp‐76—a critical adapter molecule downstream of ITAM‐containing surface receptors. The Slp‐76 Ace mutation behaved as a hypomorphic allele—while no major defects were observed in conventional T‐cell development/function, a marked defect in NK cell mediated elimination of β2‐microglobulin (β2M) deficient target cells was observed. Further studies revealed Slp‐76 to control NK‐cell receptor expression and maturation; however, activation of Slp‐76ace/ace NK cells through ITAM‐containing NK‐cell receptors or allogeneic/tumor target cells appeared largely unaffected. Imagestream analysis of the NK‐β2M−/− target cell synapse revealed a specific defect in actin recruitment to the conjugate synapse in Slp‐76ace/ace NK cells. Overall these studies establish Slp‐76 as a critical determinant of NK‐cell development and NK cell mediated elimination of missing‐self target cells in mice.


  • Open Access

    The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development

    by Siobhã¡N B. Cashman, Brian D. Marsden, Lynn B. Dustin

    Hepatitis C virus (HCV) remains a global problem despite advances in treatment. The low cost and high benefit of vaccines have made them the backbone of modern public health strategies, and the fight against HCV will not be won without an effective vaccine. Achievement of this goal will benefit from a robust understanding of virus-host interactions and protective immunity in HCV infection. In this review we summarise recent findings on HCV-specific antibody responses associated with chronic and spontaneously resolving human infection. In addition, we discuss specific epitopes within HCV’s envelope glycoproteins that are targeted by neutralizing antibodies. Understanding what prompts or prevents a successful immune response leading to viral clearance or persistence is essential to designing a successful vaccine.


  • Open Access

    Immune control and failure in HCV infection—tipping the balance

    by Lynn B. Dustin, Siobhán B. Cashman, Stephen M. Laidlaw

    Despite the development of potent antiviral drugs, HCV remains a global health problem; global eradication is a long way off. In this review, we discuss the immune response to HCV infection and particularly, the interplay between viral strategies that delay the onset of antiviral responses and host strategies that limit or even eradicate infected cells but also contribute to pathogenesis. Although HCV can disable some cellular virus-sensing machinery, IFN-stimulated antiviral genes are induced in the infected liver. Whereas epitope evolution contributes to escape from T cell-mediated immunity, chronic high antigen load may also blunt the T cell response by activating exhaustion or tolerance mechanisms. The evasive maneuvers of HCV limit sterilizing humoral immunity through rapid evolution of decoy epitopes, epitope masking, stimulation of interfering antibodies, lipid shielding, and cell-to-cell spread. Whereas the majority of HCV infections progress to chronic hepatitis with persistent viremia, at least 20% of patients spontaneously clear the infection. Most of these are protected from reinfection, suggesting that protective immunity to HCV exists and that a prophylactic vaccine may be an achievable goal. It is therefore important that we understand the correlates of protective immunity and mechanisms of viral persistence.


  • Open Access

    An ENU mutagenesis approach to dissect “self”-induced immune responses

    by Siobhan Cashman, Kristin Lampe, Rachel Sheridan, Kasper Hoebe

    The immune system exerts a critical function as it recognizes and eliminates transformed or neoplastic cells, a process also referred to as immunosurveillance. NK cells play a particularly importan...


  • Open Access

    ENU Mutagenesis in Mice - Genetic Insight into Impaired Immunity and Disease

    by Kristin Lampe, Siobhan Cashman, Halil Aksoylar, Kasper Hoebe

    ENU Mutagenesis in Mice - Genetic Insight into Impaired Immunity and Disease | InTechOpen, Published on: 2012-08-17. Authors: Kristin Lampe, Siobhan Cashman, Halil Aksoylar, et